← The Wire
ENTXNasdaq
Entera Bio Ltd.
Biological Products, (No Diagnostic Substances) · L3 · CIK 1638097
Develops first-in-class oral tablet peptide therapies for chronic conditions
$61M
Market cap
$1.65
Last close
+1.2%
1D
+11.5%
5D
474K
Volume
Price · last 39 sessions+48.6%
May 4L $1.11 · H $1.65Jun 29
161
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
SC 13GENTERA BIO LTD.Jun 30, 2021SC 13GSC 13GFeb 16, 2021SC 13GSC 13G/AFeb 16, 2021SC 13GSC 13GMar 9, 2020SC 13GSC 13GApr 10, 2019SC 13GSCHEDULE 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 13, 2019SC 13GFORM SC 13GFeb 8, 2019
Insider Activity
◆ Cluster Buy · 5 insidersIn the 90 days to Mar 9, 2026: 5 insiders bought $141K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Germano Geno JDirector | Buy | 20,000 | $1.30 | $26K |
| Mar 5, 2026 | Ellis SeanDirector | Buy | 10,000 | $1.23 | $12K |
| Feb 12, 2026 | Rubin Steven DDirector | Buy | 5,000 | $1.49 | $7K |
| Feb 10, 2026 | Germano Geno JDirector | Buy | 20,000 | $1.49 | $30K |
| Feb 10, 2026 | Taitel HayaDirector | Buy | 7,500 | $1.48 | $11K |
| Feb 9, 2026 | Ellis SeanDirector | Buy | 18,000 | $1.24 | $22K |
| Feb 9, 2026 | Rubin Steven DDirector | Buy | 10,000 | $1.20 | $12K |
| Dec 29, 2025 | Toledano Miranda JayneChief Executive Officer | Buy | 11,000 | $1.81 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance